Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovoCure

18.50
-0.0500-0.27%
Post-market: 18.750.2500+1.35%18:03 EDT
Volume:1.01M
Turnover:18.75M
Market Cap:2.03B
PE:-11.83
High:18.97
Open:18.25
Low:17.96
Close:18.55
Loading ...

NovoCure Says Optune Lua Device Gets CE Mark to Treat Lung Cancer

MT Newswires Live
·
22 Apr

BRIEF-Novocure’S Optune Lua® Receives CE Mark Approval

Reuters
·
22 Apr

Novocure announces CE Mark for Optune Lua

TIPRANKS
·
22 Apr

Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer

Business Wire
·
22 Apr

Novocure Ltd - Optune Lua Receives Ce Mark for Treatment of Mnsclc - SEC Filing

THOMSON REUTERS
·
22 Apr

NovoCure (NVCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks
·
17 Apr

Why NovoCure Stock Was Withering on Wednesday

Motley Fool
·
17 Apr

Novocure Is Maintained at Neutral by Wedbush

Dow Jones
·
16 Apr

Novocure Is Maintained at Neutral by JP Morgan

Dow Jones
·
10 Apr

Strength Seen in Bio-Techne (TECH): Can Its 10.8% Jump Turn into More Strength?

Zacks
·
10 Apr

NovoCure (NASDAQ:NVCR investor three-year losses grow to 80% as the stock sheds US$133m this past week

Simply Wall St.
·
08 Apr

Press Release: Novocure to Report First Quarter 2025 Financial Results

Dow Jones
·
01 Apr

Novocure to Report First Quarter 2025 Financial Results

THOMSON REUTERS
·
01 Apr

Wells Fargo Sticks to Its Buy Rating for NovoCure (NVCR)

TIPRANKS
·
06 Mar

Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference

Business Wire
·
04 Mar

Stock Track | NovoCure Plummets 5.3% as EPS Misses Expectations in Full-Year 2024 Results

Stock Track
·
28 Feb

NovoCure Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
28 Feb

NovoCure Ltd (NVCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Financial ...

GuruFocus.com
·
28 Feb

NovoCure (NVCR) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
28 Feb

NovoCure Reports Wider Than Expected Q4 Loss Despite 21% Jump In Sales, Expects Product Enhancements To Hit Gross Margin In 2025

Benzinga
·
28 Feb